![](/img/cover-not-exists.png)
Rate of and Response to Dose Escalation in Patients Treated With Adalimumab for Moderately-to-Severely Active Ulcerative Colitis: ULTRA 2 Subanalysis
Wolf, Doug, D’Haens, Geert, Sandborn, William, Colombel, Jean-Frédéric, Van Assche, Gert, Lazar, Andreas, Zhou, Qian, Robinson, Anne, Chao, Jingdong, Thakkar, RoopalVolume:
18
Language:
english
Journal:
Inflammatory Bowel Diseases
DOI:
10.1097/00054725-201212001-00055
Date:
December, 2012
File:
PDF, 459 KB
english, 2012